Chest
-
Slide PresentationsPRESENTED ON: Sunday, March 23, 2014 at 04:15 PM - 05:15 PMPURPOSE: The purpose of this study was to evaluated the effect of triple-combined long acting inhaled bronchodilator treatment with roflumilast and dual-combined long acting inhaled bronchodilator and single-long acting inhaled bronchodilator treatment on exacerbations in patients with severe and very severe chronic obstructive pulmonary disease(COPD). ⋯ The following authors have nothing to disclose: Alizamin Sadigov, Sakhavatdin Akhundov, Rovshan BagirovNo Product/Research Disclosure Information.
-
Bronchology CasesSESSION TYPE: Case ReportsPRESENTED ON: Sunday, March 23, 2014 at 09:00 AM - 10:00 AMINTRODUCTION: Bacterial pseudomembranous tracheobronchitis is rare in the adult. There have been two cases reported from Japan showing tracheobronchitis due to Staphylococcus Aureus requiring tracheotomy and mechanical ventilation, one of them dying from complications. In immunocompromised patients, most cases reported have been secondary to aspergillus infection and have been associated with high mortality. We present an immunocompromised patient with bacterial pseudomembranous tracheobronchitis due to post-influenza S. Aureus infection. ⋯ Bronchoscopy with visualization of airway and lower respiratory samples is essential in the management of immunocompromised patients with respiratory symptoms particularly if disproportionate to imaging findings as it may imply airway involvement.Reference #1: Yamazaki Y, Hirai K, Honda T. Pseudomembranous tracheobronchitis caused by methicillin-resistant Staphylococcus Aureus. Scand J Infect Dis 2002; 34:211-213Reference #2: Namba Y, Mihara N, Tanaka M. [Fulminant tracheobronchitis caused by methicillin-resistant Staphylococcus. Nihon Kyobu Shikkan Gakkai Zasshi 1997; 35:969-973Reference #3: Fernandez-Ruiz M, Silva JT, San-Juan R, et al. Aspergillus tracheobronchitis: report of 8 cases and review of the literature. Medicine (Baltimore) 2012; 91:261-273DISCLOSURE: The following authors have nothing to disclose: Rafael Calderon Candelario, Karen Wood, Troy SchaffernockerNo Product/Research Disclosure Information.
-
Infectious Disease Case Report Posters ISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Introduction- 65 y o M with preexisting CHF, with Ejection fraction 30%, COPD on medicines ramipril - 2.5 mg/d, eplerenone - 25 mg, aspirin and clopidogrel 75 mg, cardace- 6.25 mg, atorvastatin - 10 mg, isosorbide mononitrate 20 mg and Lasix 40 mg. ⋯ The following authors have nothing to disclose: Nabaneeta KhattarNo Product/Research Disclosure Information.
-
Asthma PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Children with asthma frequently seen in the emergency room and hospital often lack care coordination and are discharged to poorly resourced and/or chaotic environments. Affected caregivers may benefit from a central healthcare liaison who equips them to navigate clinical asthma management. The purpose of this study is to determine whether asthma education and care coordination conducted by practice-based asthma navigators improves asthma control for children. This is a preliminary report of the first 76 families enrolled and followed for one year. ⋯ The following authors have nothing to disclose: Tyra Bryant-Stephens, Caroline WestNo Product/Research Disclosure Information.
-
Tuberculosis Case Report PostersSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMPURPOSE: The aim of this presentation is to highlight the rarity of the case and use of a newer drug in successfully treating the patient. ⋯ The following authors have nothing to disclose: Sukhesh RaoNo Product/Research Disclosure Information.